Objective:Non-small cell lung cancer(NSCLC)patients with epidermal growth factor receptor(EGFR)-activating mutations have higher response rate and more prolonge
Te management of castrate-resistant prostate cancer progressing atfer maximum androgen blockade (MAB) has evolved in the last decade with the development of sev